Gene therapies are transforming rare disease treatment, enabling normal lives for some patients. However, only about 6% of 7,000 rare diseases have treatments. Advances show curative...
Merck is acquiring Mirus Bio for $600 million to accelerate growth in revolutionary technologies. CEO Belén Garijo aims to make cell and gene therapies accessible globally....